|
Volumn 23, Issue 10, 2005, Pages 2425-2426
|
Side effects and good effects from new chemotherapeutic agents: Case 2. Thalidomide-induced interstitial pneumonitis
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
C REACTIVE PROTEIN;
COTRIMOXAZOLE;
DEXAMETHASONE;
DOXORUBICIN;
GANCICLOVIR;
IMMUNOGLOBULIN G;
M PROTEIN;
MELPHALAN;
PREDNISOLONE;
THALIDOMIDE;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
ADULT;
ANAMNESIS;
ARTERIAL BLOOD;
ARTICLE;
BACKACHE;
CARBON DIOXIDE TENSION;
CASE REPORT;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG WITHDRAWAL;
DYSPNEA;
FEMALE;
FEVER;
HOSPITAL ADMISSION;
HUMAN;
HYPOXIA;
IMMUNE DEFICIENCY;
INTERSTITIAL PNEUMONIA;
LABORATORY TEST;
MULTIPLE MYELOMA;
NASOGASTRIC TUBE;
OXYGEN SUPPLY;
OXYGEN TENSION;
PHYSICAL EXAMINATION;
PNEUMOCYSTOSIS;
PRIORITY JOURNAL;
PULSE OXIMETRY;
THORAX RADIOGRAPHY;
TREATMENT OUTCOME;
AGED;
CHEMICALLY INDUCED DISORDER;
INTERSTITIAL LUNG DISEASE;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
FEMALE;
HUMANS;
LUNG DISEASES, INTERSTITIAL;
MULTIPLE MYELOMA;
THALIDOMIDE;
|
EID: 20244378693
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.04.054 Document Type: Article |
Times cited : (33)
|
References (6)
|